| Website | proteinsimple.com |
| Category | BioTech |
| Phone | (408) 510-5500 |
| Employees | |
| Founded | 2001 |
| Description | protein research |
| Total | $40.7M |
| Brightwell Technology, 5/11 | $9M |
| Convergent Bioscience, 10/10 | $12M |
| Protein Forest, 12/09 | |
| Alpha Innotech, 9/09 | $19.7M |
| Total | $85.2M |
| Series B, 1/06 Wellcome Trust Domain Associates Latterell Venture Partners Novo Ventures POSCO BioVentures Mitsui Ventures RBC Venture Partners The Vertical Group | $27M |
| Series C, 4/09 Wellcome Trust Domain Associates Latterell Venture Partners Novo A/S Mitsui Ventures Royal Bank of Canada The Vertical Group | $10M |
| Series D, 11/09 | $15M |
| Unattributed, 12/09 Novo A/S | $4M |
| Series E, 12/09 | $9.25M |
| Series F, 10/10 Essex Woodlands Health Ventures The Welcom Trust Novo A/S Domain Associates Latterell Venture Partners Royal Bank of Canada The Vertical Group Lansing Brown Investments | $20M |
Cell Biosciences is a private life sciences company focused on revolutionizing protein research through the use of nanoproteomics. Their capillary-based nanofluidic immunoassay platforms are designed for ultrasensitive detection and characterization of proteins in ultra-small biological samples. Cell Biosciences is located in Palo Alto, California.